UBS Group’s MaxLinear MXL Stock Holding History

UBS Group’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-46,200	Closed	-$1.07M	–	8613
2020 Q3	$1.07M	Hold	46,200	–	–	﹤0.01%	3582
2020 Q2	$991K	Buy	+46,200	New	+$797K	﹤0.01%	3510

Other funds holding MXL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

UBS Group's MXL Position: Q2 2026 in Review

UBS Group increased its MaxLinear (MXL) stake by 19% in Q2 2026, buying an estimated $2.75M and bringing the position to 249,018 shares worth $31.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2211.

UBS Group first reported a position in MXL in Q4 2014 and has held it in 47 quarters since. 434 funds tracked by Wall St. Rank hold MXL as of Q2 2026.

UBS Group held 249,018 shares of MaxLinear worth $31.9M as of Q2 2026.
UBS Group bought 38,892 MaxLinear shares in Q2 2026, an estimated $2.75M.
MaxLinear made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #2211 holding.
UBS Group first reported a position in MaxLinear in Q4 2014 and has held it in 47 quarters since.
434 funds tracked by Wall St. Rank held MaxLinear as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.